Skip to main content
Accessibility|Contact|Privacy|Terms|Cookies

Ebola Virus: International Regulatory Cooperation

  • Published: 2014-09-15 : Author: Health Canada : Contact: www.healthcanada.gc.ca
  • Synopsis: Medicine regulators to work together to find solutions to facilitate evaluation of and access to potential new medicines to counter Ebola outbreaks.

Main Document

The statement below was released by the International Coalition of Medicines Regulatory Authorities (ICMRA) interim Management Committee following a recent international meeting in Rio. In addition to Health Canada, members include the Therapeutic Goods Administration, Australia; National Health Surveillance, Brazil; China Food and Drug Administration, China; European Medicines Agency; European Commission - Directorate General for Health and Consumers; Health Product Regulatory Authority, Ireland; Italian Medicines Agency, Italy; Ministry of Health, Labor and Welfare, and the Pharmaceuticals and Medical Devices Agency, Japan; Medicines Evaluation Board, Netherlands; Health Sciences Authority, Singapore; Medicines Control Council, South Africa; Medicines and Healthcare Products Regulatory Agency, United Kingdom; Food and Drug Administration, United States.

The largest, most severe and most complex outbreak of Ebola virus disease in history is highlighting the absence of authorized medicines to treat or prevent this terrible disease affecting people in a number of countries in West Africa.

In the face of this outbreak, medicines regulators worldwide have committed to enhanced cooperation with the World Health Organization (WHO) and between regulatory agencies to encourage submission of regulatory dossiers and evaluation of the submitted information on potential new medicines.

This pledge was made by members of an interim International Coalition of Medicines Regulatory Authorities (ICMRA) in the margins of the 16th WHO International Conference of Drug Regulatory Authorities (ICDRA) held in Rio de Janeiro from 24-29 August 2014.

Over the past decade, research has been carried out into medicines and vaccines to protect against or to combat Ebola.

Some of the investigational medicines or vaccines studied have shown encouraging results in the laboratory and in animal models. However, they have not yet been evaluated for safety and efficacy in humans for the treatment or prevention of Ebola virus disease and may pose risks that have not yet been identified. In addition, these products may be ineffective and it is even possible that some of these investigational medicines might worsen the ultimate outcome of Ebola virus disease.

The role of medicines regulators is to evaluate the detailed evidence generated in clinical studies and to determine that the benefit risk balance of using those medicines is positive for patients in need of prevention or treatment of disease. The countries most affected by the current outbreak of Ebola virus disease often do not have reliable systems for routine data collection. In the current crisis, it is a great challenge to come up with practical solutions to ensure that meaningful data is collected and assessed so that decisions on the benefits and risks of medicines can be taken on the basis of limited scientific evidence, avoiding undue risks to patients.

Regulatory agencies therefore have pledged at their Rio de Janeiro meeting to join their expertise to consider evidence from a wide range of sources to allow for decision-making under a greater degree of scientific uncertainty.

Although the development of medicines against Ebola is ongoing, the majority of patients affected by the virus do not have access to these treatments. Regulators therefore also stress that the search for pharmaceutical interventions must not detract from the need to strengthen basic healthcare measures such as fluids and electrolytes management and to carefully observe the impact and contribution of these measures in the overall response to the disease.

It is important to note that the most effective way to combat the current Ebola outbreak is through basic public health measures, such as good infection control, isolation, contact tracing, and use of personal protective equipment.

These issues were discussed at a WHO CONSULTATION on potential Ebola therapies and vaccines on 4-5 September in Geneva with regulatory experts from leading agencies worldwide playing a key role.

Discussion

• Have your say! Add your comment or discuss this article on our FaceBook Page.

Similar Topics

1 : South Africa Ready to Deal with Ebola : Brand South Africa.
2 : Treating Ebola in the US - First Hemopurifier Shipment : Aethlon Medical, Inc..
3 : Study Predicts Likely Ebola Cases Entering UK and US Through Airport Screening : University of Liverpool.
4 : RNs to Join Global Ebola Awareness Day Actions with Vigils, Rallies and Strikes : California Nurses Association.
5 : Ebola Education Module and Safety Poster for Nurses : Disabled World.
From our Ebola Virus section - Full List (15 Items)


Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : 20 New Episodes of Letters to Lynette with Dr. Lynette Louise to Air on The Autism Channel in 2018
2 : Turnstone Center Designated as Official Paralympic Training Site by US Olympic Committee
3 : Help Your Child in School by Adding Language to The Math
4 : 50% of Retirees Saw Little or No COLA Increase in Net 2018 Social Security Benefits
5 : Turnstone Endeavor Games Concludes with National Records Broken
6 : Spinning in Circles and Learning From Myself by Tsara Shelton
7 : St. Louis HELP Medical Equipment Donation Drive Generates Record-Breaking Results
8 : People Who Snore Suffer from Palate Nerve and Muscle Damage


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

© 2004 - 2018 Disabled World™